account_balance
Investment manager · 13F filer · SEC CIK 1131399
GSK plc
Reported value$497Mas of Sep 30, 2026
Positions13 1 new, 1 sold out
Top 10 weight98.1%CRSP alone is 29%
FiledNov 536 days after quarter end
Portfolio · as of Sep 30, 2026
Where the money is
The top 10 stocks are 98.1% of this fund. 3 other stocks make up the rest.
CRSP Crispr Therapeutics AG 29.0% Trimmed −19%VIR Vir Biotechnology Inc 19.2% HeldWVE Wave Life Sciences Inc 13.6% NewBNTX Biontech Se 13.2% Trimmed −25%IDYA Ideaya Biosciences Inc 10.3% HeldCYTK Cytokinetics Inc 4.5% HeldLYEL Lyell Immunopharma Inc 3.0% HeldSPRO Spero Therapeutics Inc 2.2% HeldNKTX Nkarta Inc 1.7% HeldFULC Fulcrum Therapeutics Inc 1.3% Held
3 other stocks1.9%
Bar length compares each stock with the biggest holding. Tags compare share counts with the Jun 30, 2026 filing. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed